Skip to main content
Log in

A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice

  • Review
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate therapeutic outcomes of intraluminal brachytherapy (ILBT) for malignant obstructive jaundice (MOJ) against stent alone.

Methods

The PubMed, EMBASE, Cochrane Library, CNKI, Wan Fang, VIP and ClinicalTrials.gov databases were searched for all relevant comparative studies from the earliest available date up to 1 May 2017. Subgroup analyses were performed according to the type of study design and type of stent.

Results

Twelve studies that compared ILBT versus stent alone were eligible. A total of 641 participants with MOJ were included in our meta-analysis. A total of 340 participants were treated with intraluminal brachytherapy (ILBT); the other 301 participants were treated with biliary stent alone (stent group). ILBT was associated with lower risk of stent occlusion (OR 0.19; 95% CI 0.13–0.28; P < 0.00001) and better mean survival (MD = 3.15; 95% CI 2.64–3.66; P < 0.00001) compared with stent alone. However, the two groups were similar in number of complications (OR 0.84; 95% CI 0.45–1.56; P = 0.578), post-treatment reduced level of total bilirubin (TBIL) (MD = 22.71; 95% CI − 7.24–52.65; P = 0.14), post-treatment reduced level of direct bilirubin (DBIL) (MD = − 3.67; 95% CI − 14.09–6.75; P = 0.49), post-treatment reduced level of alanine aminotransferase (ALT) (MD = 21.09; 95% CI − 5.09–47.28; P = 0.11) and post-treatment reduced level of aspartate aminotransferase (AST) (MD = 20.86; 95% CI − 45.86–87.58; P = 0.54).

Conclusions

ILBT was significantly superior to stent alone in terms of stent occlusion and mean survival. Meanwhile, ILBT had comparable outcomes to stent alone in terms of complications and post-treatment reduced levels of TBIL, DBIL, ALT and AST. Therefore, ILBT may be considered a preferable technique for MOJ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39–47.

    Article  CAS  PubMed  Google Scholar 

  2. Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of Hilar cholangiocarcinoma. Surg Gynecol Obstet. 1992;175:579–88.

    CAS  PubMed  Google Scholar 

  3. Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488.

    Article  CAS  PubMed  Google Scholar 

  4. Han YH, Kim MY, Kim SY, Kim YH, Hwang YJ, Seo JW, et al. Percutaneous insertion of zilver stent in malignant biliary obstruction. Abdom Radiol. 2006;31:433–8.

    CAS  Google Scholar 

  5. Yasumoto T, Yokoyama S, Nagaike K. Percutaneous transcholecystic metallic stent placement for malignant obstruction of the common bile duct: preliminary clinical evaluation. J Vasc Interv Radiol. 2010;21:252–8.

    Article  PubMed  Google Scholar 

  6. Kim HS, Lee DK, Kim HG, Park JJ, Park SH, Kim JH, et al. Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. Gastrointest Endosc. 2002;55:359–65.

    Article  PubMed  Google Scholar 

  7. Monk BJ, Tewari KS, Puthawala AA, Syed AM, Haugen JA, Burger RA. Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys. 2002;52:806–15.

    Article  PubMed  Google Scholar 

  8. Guo JH, Teng GJ, Zhu GY, He SC, Fang W, Deng G, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247:574–81.

    Article  PubMed  Google Scholar 

  9. Hasimu A, Gu JP, Ji WZ, Zhang HX, Zhu DW, Ren WX. Comparative study of percutaneous transhepatic biliary stent placement with or without iodine-125 seeds for treating patients with malignant biliary obstruction. J Vasc Interv Radiol. 2017;28:583–93.

    Article  PubMed  Google Scholar 

  10. Chen Y, Wang XL, Yan ZP, Wang JH, Cheng JM, Gong GQ, et al. The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm. 2011;27:317–23.

    Article  PubMed  Google Scholar 

  11. Zhu HD, Guo JH, Zhu GY, He SC, Fang W, Deng G, et al. A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol. 2012;56:1104–11.

    Article  CAS  PubMed  Google Scholar 

  12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

    Article  CAS  PubMed  Google Scholar 

  13. Bañares R, Albillos A, Rincón D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–15.

    Article  PubMed  Google Scholar 

  14. Zhang M, Chen C, Wang X, et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of Heficobacter pylori as the rescue therapy: a meta analysis. Chin J Intern Med. 2017;56(5):368–74.

    CAS  Google Scholar 

  15. Wells GA, Shea BJ, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2000;18:727–34.

    Google Scholar 

  16. Qi X, Jia J, Bai M, et al. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a meta-analysis. J Clin Gastroenterol. 2014;49(6):495–505.

    Google Scholar 

  17. The Cochrane Collaboration: RevMan 4.2 User Guide 2005. http://www.cc-ims.net/RevMan/documentation.htm. Oxford: The Cochrane Collaboration.

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  19. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  20. Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25(11):1718–25.

    Article  PubMed  Google Scholar 

  21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Poulou LS, Thanos L, Ziakas PD. Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials. Eur J Nucl Med Mol Imaging. 2010;37(1):156–62.

    Article  PubMed  Google Scholar 

  23. Chevalier TL, Scagliotti G, Natale R, et al. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. 2005;47(1):69–80.

    Article  PubMed  Google Scholar 

  24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Han CL, Ma YL, Ou SQ, Zhao C, Meng ZB. 125I seed-strip combined with biliary stent implantation for malignant obstructive jaundice: clinical analysis of 22 cases. J Interv Radiol. 2015;24:141–5.

    Google Scholar 

  26. Jiang H, Zhao H, Zhao SM, Gu WW, Yang XH, Gu ZX, et al. Clinical efficacy evaluation of biliary stent versus biliary stent combined with 125I-seed bar implantations for the treatment of cholangiocarcinoma with obstructive jaundice. Chin J Clin Res. 2015;28:1425–8.

    Google Scholar 

  27. Pan HT, Liu HC, Fei SX, Li ZK, Wang Y, Yin YL. Clinical efficacy evaluation of biliary stent combined with 125I-seed implantations for the treatment of hilar cholangiocarcinoma with obstructive jaundice. Chin J Radiol. 2016;50:393–6.

    Google Scholar 

  28. Yao HX, Chen GS, Ye GX, Xu SQ, Wu CJ, Qin Y, et al. Biliary stent versus combined biliary stent with intracavitary irradiation using 125I seed implantation in the treatment of malignant obstructive jaundice. Chin J Hepatobiliary Surg. 2014;20:869–72.

    CAS  Google Scholar 

  29. Liu MQ, Zhuang SE, Liu LS. Clinical efficacy evaluation of biliary stent combined with 125I-seed implantations for the treatment of malignant obstructive jaundice. Fujian Med J. 2016;38:28–30.

    CAS  Google Scholar 

  30. Wang T, Liu S, Zheng YB, Song XP, Jiang WJ, Sun BL, et al. Application of 125I seeds combined with biliary stent implantation in the treatment of malignant obstructive jaundice. Chin J Oncol. 2016;38:228–31.

    CAS  Google Scholar 

  31. Chen W, Ni CF, Wang X, Huang JS, Hu CH. Percutaneous 125I seed-loaded stent implantation for the treatment of malignant obstructive jaundice: analysis of clinical efficacy. J Interv Radiol. 2015;24:138–40.

    Google Scholar 

  32. Li WH, Luo JJ, Dai ZY, Yao LZ, Dong CS, Zhu J, et al. Intraluminal brachytherapy combined with stent placement for the treatment of malignant obstructive jaundice. J Interv Radiol. 2015;24:215–8.

    Google Scholar 

  33. Zhang YY, Ma YH, Zhang FX. Clinical effectiveness analysis on biliary stent combined with 125I seed implantation in the treatment of malignant obstructive jaundice. Chin J Curr Adv Gen Surg. 2017;20:100–4.

    Google Scholar 

  34. Reniers B, Verhaegen F, Vynckier S. The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements. Phys Med Biol. 2004;49(8):1569–82.

    Article  CAS  PubMed  Google Scholar 

  35. Chino K, Silvain D, Grace A, Stubbs J, Stea B. Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System. Med Phys. 2008;35:3383–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Thanks are due to Jingjing Li, Juan Wu and Rui Zhu for assistance with the study and to Wenbin Ji for valuable discussion.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wenbin Ji.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

None.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Li, J., Wu, J. et al. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice. Cardiovasc Intervent Radiol 41, 206–217 (2018). https://doi.org/10.1007/s00270-017-1827-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-017-1827-6

Keywords

Navigation